報價延遲最少15分鐘:2025/07/03 04:07 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
20.1 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.33/-0.39
|
|
企業價值
612.74M
|
| 資產負債 |
|
每股賬面淨值
37.03
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
283.47M
|
|
每股收益
9.41
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/03 04:07 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |